Literature DB >> 18218667

Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004.

T Uhlig1, T Heiberg, P Mowinckel, T K Kvien.   

Abstract

OBJECTIVES: During the last decades major advances have occurred in the treatment of patients with rheumatoid arthritis (RA), and improvements in the burden of the disease have been suggested. We examined whether there was a secular change towards less severe disease from 1994 to 2004 among patients within the representative setting of the Oslo Rheumatoid Arthritis Register (ORAR).
METHODS: All living patients in the ORAR received a postal questionnaire in 1994, 1996, 2001 and 2004, including the Modified Health Assessment Questionnaire (MHAQ), SF-36, Arthritis Impact Measurement Scales 2 (AIMS2) and visual analogue scales for the patient global assessment of disease severity, pain and fatigue. A mixed model approach was used for longitudinal analysis adjusting for sex, age, co-morbidity, and for disease duration and DMARD if indicated.
RESULTS: The numbers of respondents aged between 20 and 79 years in 1994, 1996, 2001 and 2004 were 931, 1025, 829 and 914 patients with similar demographic characteristics (mean age in 1994 was 60.6 years, mean disease duration 12.6 years, 78% females). Health status in the population with RA was consistently improved in all dimensions of health, and this improvement was statistically significant for the physical dimension, global health and pain over the 10-year period until 2004. Both year of examination and year of disease onset had an effect on measures of longitudinal health status outcome.
CONCLUSIONS: Health status in RA improved from 1994 to 2004, probably due to access to better and more aggressive treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218667     DOI: 10.1136/ard.2007.084673

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

Review 1.  Treating Fatigue in Rheumatoid Arthritis: Does Patient Age Matter?

Authors:  Till Uhlig; Sella A Provan
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

2.  Major trends in the manifestations and treatment of rheumatoid arthritis in a multiethnic cohort in Singapore.

Authors:  Ee Tzun Koh; Justina Wei Lynn Tan; Bernard Yu-Hor Thong; Cheng Lay Teh; Tsui Yee Lian; Weng Giap Law; Arul Earnest; Kok Ooi Kong; Tang Ching Lau; Yew Kuang Cheng; Hwee Siew Howe; Wern Hui Yong; Faith Li-Ann Chia; Hiok Hee Chng; Khai Pang Leong
Journal:  Rheumatol Int       Date:  2012-12-28       Impact factor: 2.631

3.  Coping with arthritis is experienced as a dynamic balancing process. A qualitative study.

Authors:  Kjersti Grønning; Borghild Lomundal; Hege Svean Koksvik; Aslak Steinsbekk
Journal:  Clin Rheumatol       Date:  2011-09-03       Impact factor: 2.980

4.  Which patients with rheumatoid arthritis are still working?

Authors:  Till Uhlig
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

5.  Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study.

Authors:  Christie Bartels; Carolyn Bell; Ann Rosenthal; Kazuhiko Shinki; Alan Bridges
Journal:  Arthritis Rheum       Date:  2009-09

Review 6.  Is rheumatoid arthritis really getting less severe?

Authors:  Till Uhlig; Tore K Kvien
Journal:  Nat Rev Rheumatol       Date:  2009-08       Impact factor: 20.543

Review 7.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

8.  Remission makes its way to rheumatology.

Authors:  Tuulikki Sokka; Heidi Mäkinen
Journal:  Arthritis Res Ther       Date:  2010-07-14       Impact factor: 5.156

Review 9.  Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years.

Authors:  Mahboob U Rahman; Jacqui Buchanan; Mittie K Doyle; Elizabeth C Hsia; Timothy Gathany; Shreekant Parasuraman; Daniel Aletaha; Eric L Matteson; Philip G Conaghan; Edward Keystone; Désireé van der Heijde; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2011-06-27       Impact factor: 19.103

10.  Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

Authors:  T Sokka; H Kautiainen; T Pincus; S Toloza; G da Rocha Castelar Pinheiro; J Lazovskis; M L Hetland; T Peets; K Immonen; J F Maillefert; A A Drosos; R Alten; C Pohl; B Rojkovich; B Bresnihan; P Minnock; M Cazzato; S Bombardieri; S Rexhepi; M Rexhepi; D Andersone; S Stropuviene; M Huisman; S Sierakowski; D Karateev; V Skakic; A Naranjo; E Baecklund; D Henrohn; F Gogus; H Badsha; A Mofti; P Taylor; C McClinton; Y Yazici
Journal:  Ann Rheum Dis       Date:  2009-07-30       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.